Maltol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Maltol" in English language version.

refsWebsite

Global rank English rank

6doi.org

2^nd place

6nih.gov

4^th place

1dtu.dk

low place

8,755^th place

1semanticscholar.org

11^th place

8^th place

doi.org

B. D. Liboiron; K. H. Thompson; G. R. Hanson; E. Lam; N. Aebischer; C. Orvig (2005). "New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV): Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals". J. Am. Chem. Soc. 127 (14): 5104–5115. doi:10.1021/ja043944n. PMID 15810845.
N. Kaneko; H. Yasui; J. Takada; K. Suzuki; H. Sakurai (2004). "Orally administrated aluminum-maltolate complex enhances oxidative stress in the organs of mice". J. Inorg. Biochem. 98 (12): 2022–2031. doi:10.1016/j.jinorgbio.2004.09.008. PMID 15541491.
L. R. Bernstein; T. Tanner; C. Godfrey; B. Noll (2000). "Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability". Metal-Based Drugs. 7 (1): 33–48. doi:10.1155/MBD.2000.33. PMC 2365198. PMID 18475921.
D.M. Reffitt; T.J. Burden; P.T. Seed; J. Wood J; R.P. Thompson; J.J. Powell (2000). "Assessment of iron absorption from ferric trimaltol". Ann. Clin. Biochem. 37 (4): 457–66. doi:10.1258/0004563001899645. PMID 10902861.
S. Fusi; M. Frosini; M. Biagi; K. Zór; T. Rindzevicius; M.C. Baratto; L. De Vico; M.Corsini (2020). "Iron(III) complexing ability of new ligands based on natural γ-pyrone maltol" (PDF). Polyhedron. 187: 114650. doi:10.1016/j.poly.2020.114650. S2CID 225190524.
E. Cini; G. Crisponi; A. Fantasia; R. Cappai; S. Siciliano; G. Di Florio; V.M. Nurchi; M.Corsini (2024). "Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules". Biomolecules. 14: 92. doi:10.3390/biom14010092. PMC 10813012.

dtu.dk

backend.orbit.dtu.dk

S. Fusi; M. Frosini; M. Biagi; K. Zór; T. Rindzevicius; M.C. Baratto; L. De Vico; M.Corsini (2020). "Iron(III) complexing ability of new ligands based on natural γ-pyrone maltol" (PDF). Polyhedron. 187: 114650. doi:10.1016/j.poly.2020.114650. S2CID 225190524.

nih.gov

pubmed.ncbi.nlm.nih.gov

B. D. Liboiron; K. H. Thompson; G. R. Hanson; E. Lam; N. Aebischer; C. Orvig (2005). "New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV): Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals". J. Am. Chem. Soc. 127 (14): 5104–5115. doi:10.1021/ja043944n. PMID 15810845.
N. Kaneko; H. Yasui; J. Takada; K. Suzuki; H. Sakurai (2004). "Orally administrated aluminum-maltolate complex enhances oxidative stress in the organs of mice". J. Inorg. Biochem. 98 (12): 2022–2031. doi:10.1016/j.jinorgbio.2004.09.008. PMID 15541491.
L. R. Bernstein; T. Tanner; C. Godfrey; B. Noll (2000). "Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability". Metal-Based Drugs. 7 (1): 33–48. doi:10.1155/MBD.2000.33. PMC 2365198. PMID 18475921.
D.M. Reffitt; T.J. Burden; P.T. Seed; J. Wood J; R.P. Thompson; J.J. Powell (2000). "Assessment of iron absorption from ferric trimaltol". Ann. Clin. Biochem. 37 (4): 457–66. doi:10.1258/0004563001899645. PMID 10902861.

ncbi.nlm.nih.gov

L. R. Bernstein; T. Tanner; C. Godfrey; B. Noll (2000). "Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability". Metal-Based Drugs. 7 (1): 33–48. doi:10.1155/MBD.2000.33. PMC 2365198. PMID 18475921.
E. Cini; G. Crisponi; A. Fantasia; R. Cappai; S. Siciliano; G. Di Florio; V.M. Nurchi; M.Corsini (2024). "Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules". Biomolecules. 14: 92. doi:10.3390/biom14010092. PMC 10813012.

semanticscholar.org

api.semanticscholar.org

S. Fusi; M. Frosini; M. Biagi; K. Zór; T. Rindzevicius; M.C. Baratto; L. De Vico; M.Corsini (2020). "Iron(III) complexing ability of new ligands based on natural γ-pyrone maltol" (PDF). Polyhedron. 187: 114650. doi:10.1016/j.poly.2020.114650. S2CID 225190524.